Spero Therapeutics, Inc. · NASDAQ:SPRO
Anson Funds Management LP's stake in Spero Therapeutics, Inc. fell to 2.90% (Schedule 13G/A)
Event Jun 30, 2025 · Filed Aug 14, 2025
Anson Funds Management LP's stake in Spero Therapeutics, Inc. fell to 2.90%, 1,615,469 shares, as a passive investor on Jun 30, 2025. Filed Aug 14, 2025 (Schedule 13G/A).
- Stake
- 2.90%
- Shares
- 1,615,469
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 6 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Anson Funds Management LP | 2.90% | 1,615,469 |
| Anson Management GP LLC | 2.90% | 1,615,469 |
| Tony Moore | 2.90% | 1,615,469 |
| Anson Advisors Inc. | 2.90% | 1,615,469 |
| Amin Nathoo | 2.90% | 1,615,469 |
| Moez Kassam | 2.90% | 1,615,469 |